Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): A multicentre, open-label, single-arm, phase 2 trial
The Lancet Oncology | Apr 05, 2019
Randomized trials and endpoints in advanced HCC: Role of PFS as a surrogate of survival
Journal of Hepatology | Apr 05, 2019
Most read this week